MSK1 promotes cell proliferation and metastasis in uveal melanoma by phosphorylating CREB.
Conclusions: MSK1 promotes proliferation and metastasis of uveal melanoma cells by phosphorylated CREB at Ser133 residues. Therefore, MSK1 could be a promising candidate for uveal melanoma therapy and especially has tremendous potential in the treatment of cancers in which the MSK1-CREB pathway is abnormally active.
PMID: 32864007 [PubMed]
Source: Archives of Medical Science - Category: General Medicine Tags: Arch Med Sci Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Eye Cancers | General Medicine | Melanoma | Science | Skin Cancer | Uveal Melanoma